IFP Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,200
| Closed | -$37 | – | 3483 |
|
|
2024
Q2 | $37 | Buy |
2,200
+2,000
| +1,000% | +$78 | ﹤0.01% | 3187 |
|
|
2024
Q1 | $7 | Hold |
200
| – | – | ﹤0.01% | 3102 |
|
|
2023
Q4 | $83 | Hold |
200
| – | – | ﹤0.01% | 2979 |
|
|
2023
Q3 | $206 | Hold |
200
| – | – | ﹤0.01% | 3191 |
|
|
2023
Q2 | $386 | Hold |
200
| – | – | ﹤0.01% | 3233 |
|
|
2023
Q1 | $1.69K | Hold |
200
| – | – | ﹤0.01% | 2947 |
|
|
2022
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 4255 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 4448 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 4231 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 4229 |
|
|
2021
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 3166 |
|
|
2021
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 3177 |
|
|
2021
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2973 |
|
|
2021
Q1 | $2K | Buy |
+200
| New | +$1.84K | ﹤0.01% | 2735 |
|
IFP Advisors's GMDA Position: Q3 2024 in Review
IFP Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2024, closing a stake of 2,200 shares — an estimated $37 sold.
IFP Advisors first reported a position in GMDA in Q1 2021 and held it in 14 quarters. The position peaked at $2K in Q4 2022. 0 funds tracked by Wall St. Rank hold GMDA as of Q3 2024.
- IFP Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2024 after selling out during the quarter.
- IFP Advisors sold 2,200 Gamida Cell Ltd. Ordinary Shares shares in Q3 2024, an estimated $37.
- IFP Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q1 2021 and held it in 14 quarters.
- IFP Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $2K in Q4 2022.
- 0 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2024.
Based on IFP Advisors's 13F filing for Q3 2024, filed 4 Feb 2025.